Navigation Links
Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Date:9/3/2008

Company Focuses Operations, Updates Zingo Launch Progress and Adlea

Registration Strategy

Conference Call Today at 11:30 am ET

SOUTH SAN FRANCISCO, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that the company will restructure operations to focus on commercial and late-stage product development to accelerate its transition to a specialty pharmaceutical pain management company. The company also provided updates on Zingo launch progress, announced the full enrollment of its Phase 3 Adlea clinical trials and provided an update on its Adlea registration strategy.

"Since joining Anesiva in mid-June, I have conducted an extensive review of our programs, priorities and core competencies, which confirms my confidence in the underlying strength of our assets -- namely our people and pipeline," said Michael L. Kranda, president and CEO. "Based on this review we are refining our strategy and restructuring operations to drive the company toward long-term success."

"We believe these actions will expedite our ability to increase the company's value. Specifically, we will continue to strongly support the commercial growth of our first marketed product Zingo(TM), which we recently launched as an analgesic prior to peripheral IV insertions and blood draws in children ages three to 18, and the timely and comprehensive clinical development and commercialization of Adlea(TM), which is in late-stage clinical development for the management of acute pain following orthopedic surgeries. We also intend to pursue the in-licensing of late-stage products that fit within and strengthen our product portfolio," continued Mr. Kranda.

The company is re
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
2. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
3. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
4. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
5. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
6. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
7. Anesiva Defines Regulatory Pathway for Adlea with FDA
8. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
9. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... --  Precision Image Analysis (PIA) is sponsoring a ... cardiovascular imaging and post-processing. Scott D. Flamm , ... Cardiovascular Magnetic Resonance (SCMR) will be presenting this ... by providing broader access to Cardiac MRI (CMR). ... understand appropriate use of CMR, the strengths of CMR ...
(Date:4/20/2015)... April 20, 2015  Johnson & Johnson (NYSE: ... business for the investment community beginning at 8:30 a.m. ... Hyatt Regency Hotel in New Brunswick, New ... Paul Stoffels , M.D., Worldwide Chairman ... , Worldwide Chairman, Pharmaceuticals will host the meeting. ...
(Date:4/20/2015)... Apr. 14, 2015 Research and Markets ... "US Proton Therapy Outlook - Market Opportunities" ... US Proton Therapy Outlook: Market Opportunities by the author, ... home to almost 29 such centers by 2018, a ... the market will breach the Billion dollar mark to ...
Breaking Medicine Technology:Educational Webinar Teaches Improved Patient Management Through Broader Access to Cardiac MRI 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3
... importance of dedicated information management systems for radiation ... most recent version of its MOSAIQ® Oncology Information ... Systems Society,s 2012 conference (HIMSS12), Feb. 20-24, in ... comprehensive OIS that centralizes traditional radiation oncology, particle ...
... Feb. 16, 2012  Cardium Therapeutics (NYSE Amex: ... previously announced sale of 17,857,143 shares of its common ... of approximately $5.0 million, before deducting placement agent,s fees ... investors participating in the offering purchased the shares at ...
Cached Medicine Technology:Elekta Highlights Latest Version of MOSAIQ Oncology Information System at HIMSS12 Meeting 2Cardium Announces Closing of $5.0 Million Equity Financing 2Cardium Announces Closing of $5.0 Million Equity Financing 3
(Date:4/20/2015)... FL (PRWEB) April 20, 2015 Alcohol-related ... issue in the United States for decades. These ... productivity, healthcare costs and property damage each year, while ... victims, as well as their families and loved ones. ... Rehabilitation Center is dedicated to raising awareness of ...
(Date:4/20/2015)... Tympani Inc., an IT consulting and ... services business 175% this year. Tympani offers a ... to its traditional IT infrastructure, communications and managed ... cloud partners Faction and Seagate Technology, will present ... a Cloud Symposium on April 23 in Rosemont, ...
(Date:4/20/2015)... April 20, 2015 The president of ... and editor-in-chief of OncologyLive magazine argues the FDA’s ... advanced ovarian cancer is too restrictive and should be ... featured on OncLive.com, Maurie Markman, M.D., says clinical trial ... cancer who do not test positive for a BRCA ...
(Date:4/20/2015)... The 2015 Market Research Report on ... and in-depth study on the current state of ... a focus on the Chinese situation. , ... research are Pfizer, Novartis, Daiichi Sankyo, Teva, Mylan, ... Cadila Pharmaceuticals, Kangya Pharmaceuticals, Rui Ming Pharmaceutical, Zhejiang ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Catalent, ... and development solutions for drugs, biologics and consumer ... a significant project grant as part of a ... stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates. ... dependent, and the goal of the consortium is ...
Breaking Medicine News(10 mins):Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 2Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 4Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 2Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 3Health News:Recent FDA Approval of Ovarian Cancer Treatment Is Too Restrictive, Specialist in Gynecologic Malignancies Says in OncLive® Article 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 3Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 2Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 3Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 4Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 5
... GENR ) today announced that it has received,notification ... common stock,has closed below the minimum $1.00 per share ... consecutive trading days., NASDAQ also notified the Company ... a three-month period the enforcement of the rules requiring ...
... Michael Chiarello and The American Association of,Orthodontists team up to provide ... ... recipes, ST. LOUIS, Oct. 21 If ... be a sweet experience. Celebrity chef,and author Michael Chiarello, of Food ...
... Medical,International Limited (NYSE: MR ), a leading ... today that it will attend,the 60th China International ... 1., Mindray will exhibit more than 40 ... & life support products, in-vitro diagnostic,products and medical ...
... the,availability of MarketStats for health care technology equities ... a perspective on the,aforementioned equities and the opportunity ... Investors can view MarketStats by visiting: ... social networking site for,investors., Today,s MarketStats for ...
... Today,s busy consumer wants service, convenience, and quality from their physician, all ... doctor,s office is a service today,s consumer demands. Physicians can now ... , ... Copley, OH (PRWEB) October 21, 2008 -- Three out of four ...
... Gobienko,s mouth restoration dentistry in Mexico at fraction of the US cost. ... Tijuana, Mexico , in one sitting. Overseas Dentistry, including dental ... USA. , ... Burbank, CA (PRWEB) October 21, 2008 -- Andy Gobienko ...
Cached Medicine News:Health News:Genaera Receives Non-Compliance Notice From NASDAQ 2Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 2Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 3Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 4Health News:Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair 2Health News:SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX 2Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 2Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 3Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 2Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: